Total Payments
$329,617
2024 Payments
$2,478
Companies
22
Transactions
525
Medicare Patients
827
Medicare Billing
$900,718
Payment Breakdown by Category
Other$250,592 (76.0%)
Consulting$45,123 (13.7%)
Travel$21,348 (6.5%)
Food & Beverage$12,183 (3.7%)
Education$371.24 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $233,782 | 104 | 70.9% |
| Consulting Fee | $45,123 | 20 | 13.7% |
| Travel and Lodging | $21,348 | 92 | 6.5% |
| Honoraria | $16,810 | 7 | 5.1% |
| Food and Beverage | $12,183 | 294 | 3.7% |
| Education | $371.24 | 8 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ACADIA Pharmaceuticals Inc | $107,687 | 92 | $0 (2024) |
| Acorda Therapeutics, Inc | $55,265 | 60 | $0 (2023) |
| Allergan, Inc. | $35,273 | 85 | $0 (2021) |
| ABBVIE INC. | $30,827 | 57 | $0 (2024) |
| US WorldMeds, LLC | $30,608 | 77 | $0 (2020) |
| Teva Pharmaceuticals USA, Inc. | $29,561 | 33 | $0 (2021) |
| Kyowa Kirin, Inc. | $17,090 | 19 | $0 (2024) |
| Lundbeck LLC | $13,745 | 18 | $0 (2018) |
| Boston Scientific Corporation | $2,824 | 7 | $0 (2023) |
| Sage Therapeutics, Inc. | $1,866 | 12 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,478 | 26 | ABBVIE INC. ($1,967) |
| 2023 | $8,609 | 17 | ACADIA Pharmaceuticals Inc ($8,039) |
| 2022 | $2,626 | 18 | Sage Therapeutics, Inc. ($1,866) |
| 2021 | $52,892 | 52 | Teva Pharmaceuticals USA, Inc. ($12,755) |
| 2020 | $33,287 | 74 | Acorda Therapeutics, Inc ($10,732) |
| 2019 | $113,729 | 181 | ACADIA Pharmaceuticals Inc ($37,973) |
| 2018 | $59,270 | 79 | ACADIA Pharmaceuticals Inc ($27,112) |
| 2017 | $56,727 | 78 | ACADIA Pharmaceuticals Inc ($28,863) |
All Payment Transactions
525 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | ABBVIE INC. | VYALEV (Drug) | Consulting Fee | Cash or cash equivalent | $1,300.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $59.46 | General |
| 12/04/2024 | ABBVIE INC. | — | Travel and Lodging | In-kind items and services | $268.71 | General |
| 12/03/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $44.43 | General |
| Category: AMANTADINE | ||||||
| 10/25/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $25.87 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2024 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $28.15 | General |
| Category: Adenosine A2A Receptors | ||||||
| 10/04/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $44.80 | General |
| Category: AMANTADINE | ||||||
| 10/04/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: AMANTADINE | ||||||
| 09/21/2024 | ACADIA Pharmaceuticals Inc | — | Food and Beverage | In-kind items and services | $144.45 | General |
| 09/10/2024 | ABBVIE INC. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $25.51 | General |
| Category: NEUROSCIENCE | ||||||
| 08/28/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $10.03 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/22/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: AMANTADINE | ||||||
| 08/21/2024 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $27.45 | General |
| Category: Adenosine A2A Receptors | ||||||
| 08/07/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: AMANTADINE | ||||||
| 08/07/2024 | ABBVIE INC. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $7.23 | General |
| Category: NEUROSCIENCE | ||||||
| 07/31/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $120.64 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $8.73 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/17/2024 | Noctrix Health, Inc. | NIDRA (Device) | Food and Beverage | Cash or cash equivalent | $81.81 | General |
| Category: Restless Leg Syndrome | ||||||
| 07/03/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: AMANTADINE | ||||||
| 06/24/2024 | Medtronic, Inc. | PERCEPT PC BRAINSENSE (Device) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: Deep Brain Neurostimulation | ||||||
| 06/20/2024 | GE HEALTHCARE | — | Food and Beverage | In-kind items and services | $15.42 | General |
| 06/20/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $8.24 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 06/04/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: AMANTADINE | ||||||
| 05/30/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $124.80 | General |
| Category: NEUROSCIENCE | ||||||
| 04/25/2024 | Medtronic, Inc. | PERCEPT PC BRAINSENSE (Device) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: Deep Brain Neurostimulation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 210 | 40,874 | $774,160 | $213,689 |
| 2022 | 10 | 189 | 44,262 | $809,270 | $226,277 |
| 2021 | 6 | 152 | 43,378 | $762,335 | $218,976 |
| 2020 | 9 | 276 | 45,705 | $711,237 | $241,776 |
Total Patients
827
Total Services
174,219
Medicare Billing
$900,718
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 27 | 21,400 | $428,000 | $106,098 | 24.8% |
| J0588 | Injection, incobotulinumtoxin a, 1 unit | Office | 2023 | 27 | 19,100 | $191,000 | $77,431 | 40.5% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2023 | 32 | 91 | $77,370 | $12,931 | 16.7% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2023 | 43 | 110 | $32,585 | $7,461 | 22.9% |
| 64642 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | Office | 2023 | 13 | 29 | $21,260 | $3,550 | 16.7% |
| 95983 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, first 15 minutes with qualified health professional | Office | 2023 | 16 | 57 | $10,110 | $2,246 | 22.2% |
| 95984 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, each additional 15 minutes with qualified health professional | Office | 2023 | 11 | 43 | $6,495 | $1,400 | 21.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 24 | 27 | $3,655 | $1,308 | 35.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 17 | 17 | $3,685 | $1,264 | 34.3% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 26 | 23,103 | $462,000 | $112,347 | 24.3% |
| J0588 | Injection, incobotulinumtoxin a, 1 unit | Office | 2022 | 21 | 20,801 | $208,000 | $82,965 | 39.9% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2022 | 27 | 84 | $51,745 | $9,853 | 19.0% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2022 | 37 | 121 | $33,095 | $8,874 | 26.8% |
| 64642 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | Office | 2022 | 11 | 34 | $21,880 | $4,037 | 18.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 12 | 26 | $7,985 | $2,782 | 34.8% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 14 | 14 | $8,215 | $1,618 | 19.7% |
| 11105 | Punch biopsy, each additional skin growth | Office | 2022 | 14 | 28 | $7,900 | $1,506 | 19.1% |
| 95983 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, first 15 minutes with qualified health professional | Office | 2022 | 11 | 34 | $6,210 | $1,451 | 23.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 16 | 17 | $2,240 | $845.03 | 37.7% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 33 | 22,159 | $443,000 | $107,443 | 24.3% |
| J0588 | Injection, incobotulinumtoxin a, 1 unit | Office | 2021 | 24 | 20,958 | $209,505 | $84,552 | 40.4% |
| 64616 | Injection of chemical for destruction of nerve muscles on one side of neck excluding voice box accessed through the skin | Office | 2021 | 28 | 84 | $54,590 | $11,252 | 20.6% |
| 95874 | Needle measurement and recording of electrical activity of muscles for guidance with injection of chemical for destruction of muscles | Office | 2021 | 39 | 116 | $29,580 | $8,737 | 29.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 17 | 36 | $11,160 | $3,951 | 35.4% |
| 64642 | Injection of chemical for destruction of nerve muscles on one arm or leg, 1-4 muscles | Office | 2021 | 11 | 25 | $14,500 | $3,041 | 21.0% |
About Dr. Joy Demarcaida, M.D
Dr. Joy Demarcaida, M.D is a Neurology healthcare provider based in Vernon, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1841296951.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joy Demarcaida, M.D has received a total of $329,617 in payments from pharmaceutical and medical device companies, with $2,478 received in 2024. These payments were reported across 525 transactions from 22 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($233,782).
As a Medicare-enrolled provider, Demarcaida has provided services to 827 Medicare beneficiaries, totaling 174,219 services with total Medicare billing of $900,718. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Vernon, CT
- Active Since 06/23/2005
- Last Updated 07/19/2022
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1841296951
Products in Payments
- NUPLAZID (Drug) $107,542
- INBRIJA (Drug) $54,971
- AUSTEDO (Drug) $29,130
- BOTOX (Biological) $25,969
- Duopa (Drug) $19,635
- NOURIANZ (Drug) $17,034
- APOKYN (Drug) $15,786
- NORTHERA (Drug) $13,745
- Xadago (Drug) $9,693
- BOTOX (Drug) $9,454
- DUOPA (Drug) $9,230
- MYOBLOC (Biological) $5,150
- SPECTRA WAVEWRITER (Device) $2,239
- Dhivy (Drug) $1,831
- VYALEV (Drug) $1,326
- ACTIVA (Device) $921.65
- GOCOVRI (Drug) $241.76
- INGREZZA (Drug) $228.81
- GENERAL THERAPIES (Device) $193.07
- Gocovri (Drug) $174.49
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.